Based on our hypothesis that shedding of stress-induced ligands on tumor cells generates peptide remnants, which may function as targetable neoepitopes, we generated antibodies against an MICB-derived octapeptide with prevalence in malignant and stressed cells. The gene discussed is MICB; the disease is neoplasm.